FIELD: biotechnology.
SUBSTANCE: cell line can be used, for example to create antitumor vaccines (whole-cell or genetic engineering), testing of activity of various pharmaceuticals, creation of diagnostic kits and test systems for development of new medicines. The cell line is deposited in the Russian national collection of industrial microorganisms (RNCIM) under the registration number H-152.
EFFECT: obtained new cell line of human kidney cancer IBGVAT R 27 has stable cultural and morphological characteristics.
1 ex
| Title | Year | Author | Number |
|---|---|---|---|
| CELL LINE OF HUMAN KIDNEY CANCER IBGVAT R 6 | 2014 |
|
RU2573940C1 |
| APPLICATION OF CELL LINE OF RC291C CLEAR CELL ADENOCARCINOMA | 2018 |
|
RU2673729C1 |
| COMBINED CELL TRANSPLANT BASED ON LYMPHOKINE-ACTIVATED KILLERS AND DENDRITE CELLS, METHOD FOR PRODUCTION THEREOF AND METHOD FOR TREATMENT AND PROPHYLAXIS OF MALIGNANT, INFECTIVE DISEASES AND IMMUNODEFICIENT CONDITIONS | 2006 |
|
RU2309753C1 |
| METHOD OF PRODUCING ANTIGEN-SPECIFIC CYTOTOXIC CELLS HAVING ACTIVITY AGAINST BREAST CANCER CELLS | 2013 |
|
RU2596920C2 |
| IMMUNOTHERAPY OF BREAST CANCER USING ANTIGEN-ACTIVATED DENDRITIC CELLS | 2016 |
|
RU2645464C1 |
| METHOD FOR STIMULATING PRESENTING ACTIVITY OF DENDRITIC CELLS | 2019 |
|
RU2728592C1 |
| AUTOLOGOUS VACCINE FOR ONCOTHERAPY AND METHOD FOR PREPARING THEREOF | 2008 |
|
RU2392946C2 |
| HUMAN MELANOMA CELL LINE PG WHICH SECRETES RECOMBINANT GRANULOCYTIC-MACROPHAGAL COLONY-STIMULATING FACTOR | 2008 |
|
RU2395570C1 |
| HUMAN MELANOMA CELL LINE 26G WHICH SECRETES RECOMBINANT GRANULOCYTIC-MACROPHAGAL COLONY-STIMULATING FACTOR | 2008 |
|
RU2395571C1 |
| HUMAN MELANOMA CELL LINE 31G WHICH SECRETES RECOMBINANT GRANULOCYTIC-MACROPHAGAL COLONY-STIMULATING FACTOR | 2008 |
|
RU2395573C1 |
